176
Tarsus Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
225
FY23:
256
FY24:
357
FY25:
523
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.96
FY22:
2.49
FY23:
9.36
FY24:
20.3
FY25:
39.4
Total assets
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
228
FY23:
265
FY24:
377
FY25:
562
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.5
FY22:
15.4
FY23:
36.9
FY24:
80.6
FY25:
136
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.70
FY22:
19.5
FY23:
31.6
FY24:
71.8
FY25:
83.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
193
FY23:
197
FY24:
225
FY25:
343
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
228
FY23:
265
FY24:
377
FY25:
562
All amounts in millions USD